Safety of combination of methotrexate (MTX) and infliximab (IFX) in a large Belgian observational patient cohort with refractory rheumatoid arthritis.

Durez, Patrick; Vandenbosch, F.; Corluy, L; Van den Bossche, N; Schuerwegh, A; De Clerck, L.; Peretz, A.; Malaise, Michel; Devogelaer, Jean-Pierre; Westhovens, Rene

Safety of combination of methotrexate (MTX) and infliximab (IFX) in a large Belgian observational patient cohort with refractory rheumatoid arthritis.

Durez, Patrick

;

Vandenbosch, F.

;

Corluy, L

;

Van den Bossche, N

;

Westhovens, Rene

;et.al.

(2002) 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Location: NEW ORLEANS (Louisiana) (24.October.2002)

Files

No attached file found for this publication.

Details

Authors

Durez, PatrickUCLouvain
Author
Vandenbosch, F.
Author
Corluy, L
Author
Van den Bossche, N
Author
Devogelaer, Jean-PierreUCLouvain
Author
Westhovens, ReneUCLouvain
Author

Affiliations

UCLouvain

Citations

APA
Chicago
FWB

Durez, P., Vandenbosch, F., Corluy, L., Van den Bossche, N., Schuerwegh, A., De Clerck, L., Peretz, A., Malaise, M., Devogelaer, J.-P., & Westhovens, R. (2002). Safety of combination of methotrexate (MTX) and infliximab (IFX) in a large Belgian observational patient cohort with refractory rheumatoid arthritis. Arthritis & Rheumatism, 46(9), S536-S536. https://hdl.handle.net/2078.5/141652 (Original work published 2002)